Cargando…

Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go

Heart failure is a clinically complex syndrome that results due to the failure of the ventricles to function as pump and oxygenate end organs. The repercussions of inadequate perfusion are seen in the form of sympathetic overactivation and third spacing, leading to clinical signs of increased blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Gajjela, Harini, Kela, Iljena, Kakarala, Chandra L, Hassan, Mohammad, Belavadi, Rishab, Gudigopuram, Sri Vallabh Reddy, Raguthu, Ciri C, Modi, Srimy, Sange, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751580/
https://www.ncbi.nlm.nih.gov/pubmed/35028235
http://dx.doi.org/10.7759/cureus.20359
_version_ 1784631706737704960
author Gajjela, Harini
Kela, Iljena
Kakarala, Chandra L
Hassan, Mohammad
Belavadi, Rishab
Gudigopuram, Sri Vallabh Reddy
Raguthu, Ciri C
Modi, Srimy
Sange, Ibrahim
author_facet Gajjela, Harini
Kela, Iljena
Kakarala, Chandra L
Hassan, Mohammad
Belavadi, Rishab
Gudigopuram, Sri Vallabh Reddy
Raguthu, Ciri C
Modi, Srimy
Sange, Ibrahim
author_sort Gajjela, Harini
collection PubMed
description Heart failure is a clinically complex syndrome that results due to the failure of the ventricles to function as pump and oxygenate end organs. The repercussions of inadequate perfusion are seen in the form of sympathetic overactivation and third spacing, leading to clinical signs of increased blood pressure, dyspnea, fatigue, palpitations, etc. This article provided a brief overview of the clinical syndrome of heart failure; its epidemiology, risk factors, symptoms, and staging; and the mechanisms involved in disease progression. This article also described several landmark trials in heart failure that tested the efficacy of first-line drugs such as beta-blockers, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and the latest drugs in the field of heart failure: angiotensin receptor neprilysin inhibitors. Most studies described in this article were guideline-setting trials that revolutionized the practice of medicine and cardiology.
format Online
Article
Text
id pubmed-8751580
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-87515802022-01-12 Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go Gajjela, Harini Kela, Iljena Kakarala, Chandra L Hassan, Mohammad Belavadi, Rishab Gudigopuram, Sri Vallabh Reddy Raguthu, Ciri C Modi, Srimy Sange, Ibrahim Cureus Cardiology Heart failure is a clinically complex syndrome that results due to the failure of the ventricles to function as pump and oxygenate end organs. The repercussions of inadequate perfusion are seen in the form of sympathetic overactivation and third spacing, leading to clinical signs of increased blood pressure, dyspnea, fatigue, palpitations, etc. This article provided a brief overview of the clinical syndrome of heart failure; its epidemiology, risk factors, symptoms, and staging; and the mechanisms involved in disease progression. This article also described several landmark trials in heart failure that tested the efficacy of first-line drugs such as beta-blockers, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and the latest drugs in the field of heart failure: angiotensin receptor neprilysin inhibitors. Most studies described in this article were guideline-setting trials that revolutionized the practice of medicine and cardiology. Cureus 2021-12-12 /pmc/articles/PMC8751580/ /pubmed/35028235 http://dx.doi.org/10.7759/cureus.20359 Text en Copyright © 2021, Gajjela et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Gajjela, Harini
Kela, Iljena
Kakarala, Chandra L
Hassan, Mohammad
Belavadi, Rishab
Gudigopuram, Sri Vallabh Reddy
Raguthu, Ciri C
Modi, Srimy
Sange, Ibrahim
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
title Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
title_full Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
title_fullStr Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
title_full_unstemmed Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
title_short Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
title_sort milestones in heart failure: how far we have come and how far we have left to go
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751580/
https://www.ncbi.nlm.nih.gov/pubmed/35028235
http://dx.doi.org/10.7759/cureus.20359
work_keys_str_mv AT gajjelaharini milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo
AT kelailjena milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo
AT kakaralachandral milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo
AT hassanmohammad milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo
AT belavadirishab milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo
AT gudigopuramsrivallabhreddy milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo
AT raguthuciric milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo
AT modisrimy milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo
AT sangeibrahim milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo